Evgen Appoints CMO
This article was originally published in Scrip
Evgen Pharma Plc., a company focused on cancer and neurological conditions, has appointed Hamina J. Patel chief medical officer. She brings over 15 years' experience to the company having previously been director of drug development, oncology at Johnson and Johnson. Patel has also worked in the development of biopharmaceuticals at Celltech and at Chugai.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.